Urethrocutaneous fistula after use of Tegress bulking agent: Case report and review of the literature.
We report a case of a 68-year-old man who presented with a urethrocutaneous fistula after off-label use of Tegress (C. R. Bard, Inc., Murray Hill, NJ) Urethral Implant for post-prostatectomy incontinence. He was treated for prostate cancer with an open radical retropubic prostatectomy and adjuvant external beam radiation therapy. He was treated unsuccessfully for stress incontinence with a Tegress Urethral Implant and presented to our clinic initially with extrusion of the material urethrally. Four years later he re-presented with a large bullous skin lesion on his suprapubic area. Contrast-enhanced magnetic resonance imaging and retrograde urethral cystogram demonstrated a urethrocutaneous fistula. Subsequent cystoscopy revealed the calcified extruded material in the same location as the site of Tegress injection. The patient underwent simple cystectomy with ileal diversion. He recovered well postoperatively. This appears to be the first reported case of urethrocutaneous fistula after use of a Tegress Urethral Implant for post-prostatectomy stress urinary incontinence.
Department of Urology, University of Michigan Hospitals and Health Centers, Ann Arbor, MI.
Anudeep
A
Mukkamala
Department of Urology, University of Michigan Hospitals and Health Centers, Ann Arbor, MI.
Jerilyn M
JM
Latini
Department of Urology, University of Michigan Hospitals and Health Centers, Ann Arbor, MI.
Anne P
AP
Cameron